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Abstract
The standard treatment of ureteropelvic junction obstruction (UPJO) is 
represented by the Anderson-Hynes dismembered pyeloplasty, even if different 
approaches, both surgical and endoscopic, have been described. Robot-assisted 
pyeloplasty (RP) is a feasible and safe approach. The indications for the robotic 
approach remain the same as those for the laparoscopic or open pyeloplasty. 
Every patient with symptomatic UPJO, or with decreasing renal function in the 
presence of UPJO, should undergo RP. The transperitoneal, retroperitoneal, and 
transmesocolic approaches are described focusing on advantages and disadvan-
tages of each approach. Robot-assisted pyeloplasty has excellent success rates for 
relief of obstruction and very low peri- and post-operative morbidity. The robotic 
surgical technique maintains the advantages of laparoscopic surgery provid-
ing a more precise manipulation and visualization, and a faster learning curve. 
Comparative studies are reported to confront the different techniques. Secondary 
minimally invasive pyeloplasty is obviously a more challenging procedure due 
to the fibrosis and the adhesions formed after the previous surgery. Newer 
techniques and indications such as the employment of buccal mucosal graft, the 
single port approach, and indocyanine green injection are described. Tips and 
tricks to keep in mind during this kind of procedure are listed in order to report 
our experience in this setting.
Keywords: ureteropelvic junction obstruction, robot-assisted pyeloplasty,  
robotic surgery
1. Introduction
The standard treatment of ureteropelvic junction obstruction (UPJO) is 
represented by the Anderson-Hynes dismembered pyeloplasty, even if different 
approaches, both surgical and endoscopic, have been described.
The Anderson-Hynes dismembered pyeloplasty was first described in 1993 by 
Schuessler et al. [1], and the laparoscopic approach has become the gold standard in 
alternative to the open approach as the long-term outcomes are comparable between 
the two techniques with success rates from 90 to >95% [2–5]. However, laparoscopic 
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pyeloplasty, both through a transperitoneal and a retroperitoneal approach, 
remains a challenging procedure and it requires high proficiency in laparoscopic 
skills especially due to the reconstructive part. In fact, even in large series of referral 
centers, the operative time remains extensive.
The robot-assisted laparoscopic approach overcomes the limits of conventional 
laparoscopy thanks to the three-dimensional vision, increased tools dexterity, 
and greater precision. Therefore, considering the reconstruction skills needed for 
intracorporeal suturing, dismembered pyeloplasty most benefits from the robotic 
assistance.
Robotic pyeloplasty (RP) using the Da Vinci (Intuitive Surgical, Inc., Sunnyvale, 
CA, USA) system has been first described by Gettman et al. in 2002 [6], reporting 
perioperative outcomes of 9 patients treated with robotic transperitoneal pyelo-
plasty for UPJO.
1.1 Indications to robotic dismembered pyeloplasty
The indications for the robotic approach remain the same as those for the 
laparoscopic or open pyeloplasty. Every patient with symptomatic UPJO, 
or with decreasing renal function in the presence of UPJO, should undergo 
RP. Additionally, patients that failed primary treatment, the robotic approach could 
be considered.
The diagnostic workout mirrors the one for the open and laparoscopic 
approach. The patients should undergo diuretic MAG4 renogram and CT scan to 
evaluate the anatomy, such as the presence of a crossing vessel and the eventual 
presence of renal calculi to plan the surgical strategy accordingly.
2. Surgical strategies
2.1 Transperitoneal approach for robot-assisted pyeloplasty
2.1.1 Operating room setup
The patient is placed at a 60° full flank position exposing upward the affected 
side. The two arms are placed on an arm board and alongside the patient’s flank, 
respectively. Both legs are fully extended and the upper one is abducted with one or 
two pillows placed in between. Extension of the operating table is performed break-
ing the patient’s flack midway between the iliac crest and the costal margin to obtain 
a broader operating field (Figure 1).
The OR setup can be seen in Figure 2. Anesthesia takes position at the head of 
the patient. The robotic cart is coming from the patient’s back.
2.1.2 Robotic ports
The optic trocar is placed at the level of the umbilicus, for esthetic reasons, or on 
pararectal line for obese patients always at the umbilical level. Trocars of 12 or 8 mm 
are used for the Si and Xi DaVinci system, respectively. Either a 30° or a 0° camera 
is employed depending on the operator preference. The two operative robotic ports 
are positioned at the midpoint between the anterior superior iliac spine and the 
umbilicus and on the pararectal line at least 1 cm below the costal arch. The 5-mm 
assistant port is placed cranially in respect to the camera port at the midpoint 
between the umbilicus and the xiphoid process (Figure 3).
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2.1.3 Procedure step-by-step
After the medialization of the colon, on the right side, the overlying Gerota’s fascia 
is incised, while on the right side, the white line of Toldt is incised and the left colon 
is mobilized medially. Despite the side, the target structures (the ureter, the dilated 
renal pelvis, and eventually the aberrant crossing vessels) are exposed. The ureter 
can be visualized by following the psoas muscle medially starting from the lower 
pole of the kidney. Any crossing vessels are identified and preserved. The UPJ is fully 
mobilized using both blunt and sharp dissection. Bipolar fenestrated forceps and 
monopolar scissors are employed in this phase.
When the UPJ is isolated and the obstruction is identified, section of the 
ureter is performed. In case of a severe dilation of the pelvis, the redundant por-
tion should be excised. The presence of renal calculi in the renal pelvis implies its 
removal with the employment of a flexible cystoscope. The ureter is then spatulated 
Figure 1. 
Patient’s position for transperitoneal robotic pyeloplasty.
Figure 2. 
Operating theater setup for transperitoneal robotic pyeloplasty.
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longitudinally up to the visualization of healthy tissue; the pyeloplasty is then 
performed according to the Anderson-Hynes technique. Two 4-0 Vicryl running 
sutures are preferred for the anastomosis, one for the posterior and the other for the 
anterior plate using a robotic needle driver.
In the case of a crossing vessel, a dismembered pyeloplasty is performed with 
anterior transposition of the ureteral anastomosis in respect to the blood vessels.
2.2 Retroperitoneal approach for robot-assisted pyeloplasty
2.2.1 Operating room setup
As seen in Figure 4, the patient is placed in a full flank position with the 
operating table extended to maximize the operating field. The robotic system is 
placed in order to enter the arms anteriorly of 25–30° in respect to the head of the 
patient.
Figure 3. 
Port placement for transperitoneal robotic pyeloplasty.
Figure 4. 
Patient’s position for retroperitoneal robotic pyeloplasty.
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2.2.2 Robotic ports
A retroperitoneal access is performed at the level of the tip of the 12th rib. A 
Balloon expander or other cost-effective alternatives (such as a finger of sterile gloves 
tied to a trocar and filled with saline water) [7] are used to create a working space 
in the retroperitoneal fat. The two operative ports are positioned at the crossover 
of the 12th rib and the erector spinae muscle and at the level of the anterior axillary 
line 6–8 cm cranially to the iliac crest, respectively. A 5-mm trocar for the assistant is 
positioned along the erector spinae muscle, cranially to the iliac crest (Figure 5).
2.2.3 Procedure step-by-step
The Gerota’s fascia is excised and the UPJ is exposed. The plasty mirrors the 
transperitoneal approach.
2.3 Transperitoneal versus retroperitoneal access
Cestari et al. [5] reported outcomes of 36 and 19 patients who underwent 
retroperitoneal and transperitoneal robotic pyeloplasty, respectively. They stated 
that either the transperitoneal or retroperitoneal approach is feasible and safe, 
comparable in terms of operative time, estimated blood loss, and postoperative 
complications. No cases of conversion were reported.
Regarding the transperitoneal approach, given the wider working space, it is 
usually preferred in case of a wide renal pelvis (>6 cm), presence of pelvic calculi, 
crossing vessels, renal malformations (i.e., horseshoe kidney), or pelvic kidney.
The advantage of the retroperitoneal access comprehends a direct exposure of 
the UPJ without the opening of the peritoneal cavity and minimizing intraperito-
neal organs injury. However, the lack of familiar anatomical reference structures 
and a narrow operative space are limitations of this approach. Additionally, using 
a retroperitoneal access gives the possibility to manage conservatively urinary 
fistulas, since urine will remain in the retroperitoneal cavity.
2.4 Transmesocolic approach for the left robot-assisted pyeloplasty
Gupta et al. reported in 2009 the transmesocolic access for the left UPJO [8] 
through an incision of the mesocolon. This approach allows the operator to access 
directly the left renal pelvis and UPJ without mobilizing the descending colon.
Figure 5. 
Port placement for retroperitoneal robotic pyeloplasty.
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The best candidates for this approach are young thin patients, with a large renal 
pelvis. In the case of renal calculi or either previous or present history of a compli-
cated ureteropelvic junction obstruction, a transperitoneal approach might be the 
access of choice.
The transmesocolic approach brings advantages such as a shorter mean operative 
time and hospital stay, and a faster bowel peristalsis recovery as described in the 
literature [9, 10].
2.5 Ureteral stenting in robot-assisted pyeloplasty
A ureteral stent is necessary to protect the anastomosis from high renal intra-
pelvic pressure. Therefore, a ureteral stent is usually placed during the procedure 
either in a retrograde or anterograde fashion.
Retrograde stent placement is performed in the operating room before the pro-
cedure. A retrograde pyelogram during the double J position can exclude any other 
ureteric abnormalities. However, it is more time-consuming as the patient is before 
proceeding with the surgery; moreover, stenting results in the collapse of the renal 
pelvis, making the identification of the UPJ stricture more difficult.
Anterograde stenting consists in putting the ureteral double-J stent during 
the pyeloplasty. In this way, the collapse of the renal pelvis is avoided. Usually, a 
hydrophilic guidewire and a 5-Fr ureteral catheter are inserted through the 5-mm 
trocar after suturing the posterior aspect of the anastomosis. The guidewire and 
the catheter are pushed within the ureter with a robotic grasper or a needle driver 
down to the bladder. Then, the ureteral catheter is removed and the double-J 
stent is placed onto the guidewire. After the stent placement, the anterior aspect 
of the anastomosis is completed. This technique is safe, feasible and time-saving 
[11]. Disadvantage consists in the blind placement of the stent. Correct stent 
placement can be assured by fluoroscopy or an abdominal X-Ray; another 
technique has been reported by Rodrigues et al. [12] using methylene blue to fill 
the bladder and its appearance through the stent holes as an indicator of correct 
positioning.
Gaitonde et al. [13] used a cystoscopically placed ureteropelvic junction occlu-
sion catheter positioned along with a marked Foley urethral catheter to display 
the distance required to accurately position the lower coil of the stent into the 
bladder. The Foley and the occlusion balloon are prepared and after pyelotomy, 
the balloon is deflated, and the occlusion catheter is withdrawn into the proximal 
ureter. After completing the posterior aspect of the anastomosis, a guidewire is 
inserted through the catheter and grasped at the kidney pelvis. The occlusion 
catheter is then removed and the stent pushed along the guidewire up to the renal 
pelvis. The distal end of the stent pusher was advanced until the calibrated mark 
of the Foley catheter appears to ensure the correct positioning of the distal coil in 
the bladder.
Fiori et al. reported flexible pneumocystoscopy as safe and feasible in placing 
a retrograde ureteral stent in the setting of laparoscopic pyeloplasty. In this way, 
the patient can be placed directly on the flank position and the reconstruction can 
proceed [14].
Studies comparing retrograde versus an anterograde stenting approach 
have been done. For all the studies, the setting is the laparoscopic pyeloplasty. 
Anterograde stenting is quicker; however, retrograde stenting appears to ensure a 
higher success rate in correct stent placement [15–18]. Stentless pyeloplasty has also 
been reported; however, very few and conflicting reports evaluate the safety and 
the efficacy of a stentless approach [19–21].
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2.6 Postoperative management
Patient’s mobilization and feeding can start postoperative day 1. The bladder 
catheter is usually removed on postoperative day 2 and the drain the following day 
if the output is less than 50–70 mL; patients are discharged on the same day.
Stent removal occurs after 4 weeks postoperatively. On the same occasion, 
urinalysis, urine culture, and abdominal ultrasound can be prescribed in order to 
assess the short-term operative outcome.
Patients are then evaluated at 6 and 12 months with urinalysis, urine culture, 
MAG3 renogram, and URO-CT scan.
3. Surgical outcomes
Robot-assisted pyeloplasty has excellent success rates for relief of obstruction 
and very low peri- and post-operative morbidity. The robotic surgical technique 
maintains the advantages of laparoscopic surgery, providing a more precise manip-
ulation and visualization and a faster learning curve.
Several methods and variables may be adopted to define resolution of the 
obstruction including radiology and nuclear medicine tests (renogram, intravenous 
pyelogram, or ultrasound), symptom resolution, and laboratory analysis.
Ultrasound can lead to an incorrect interpretation of obstruction resolution as 
the persistent residual hydronephrosis can be seen for months or longer after the 
procedure.
Renal scintigraphy is widely recognized as the best noninvasive imaging modal-
ity to define the obstruction and it is employed in the evaluation of the postopera-
tive outcomes.
The first experience with robot-assisted Anderson-Hynes pyeloplasty was 
published by Getmann et al. in 2002 [6]. The authors reported outcomes of 9 
consecutive patients treated with transperitoneal robotic pyeloplasty. No surgical 
conversion was reported and 1 patient underwent an open surgery in the second 
place because of a urinary fistula. Favorable outcome for all patients was reported at 
4 months follow-up.
Patel published a 50-patient series reaching 100% of success rate. Operative 
success was defined by a negative MAG3 renography. The authors stated that this 
technique offers short-term efficacy and a very low rate of complications, with a 
quick learning curve [22].
Mufarrij et al. reported a multi-institutional series of 140 patients, with 
29 months follow-up, including both primary and secondary UPJO. The suc-
cess rate reached the 96% of the cases and recurrence was reported in six cases. 
Complication rate was 7.1% and, postoperatively, double-J stent migration was 
the most common complication. As for minor complications, fever was the most 
frequently described [23].
Schwentner et al. published in 2007. A large series of 92 patients, 80 with 
primary obstruction and 12 with secondary ones, were described. The follow-up 
reached up to 40 months and the success rate was 96%. In the secondary obstruc-
tion, the arm failure rate after RP was slightly higher [24].
The optimal results of the robotic procedure were confirmed in another multi-
institutional large series of 169 patients, both primary and secondary obstructions 
being taken into account. The success rate reached 97.6% with 39 months follow-up. 
The mean estimated blood loss (EBL) was around 50 mL and the complication rate 
was 6.6% [25].
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Authors Number 
of 
patients
Tranperitoneal vs. 
retroperitoneal approach
Operative time (min) Conversion rate (%) Complication rate (%) Hospital stay 
(days)
Follow-up (months)
Patel [22] 50 Transperitoneal 122 0 32 1.1 11.7
Olsen et al. 
[30]
67 Retroperitoneal 146 1.5 17.9 2 12.1
Schwentner 
et al. [24]
92 Transperitoneal 108 0 NA 4.6 39.1
Mufarrij 
et al. [23]
140 Transperitoneal 217 0 10 2.1 29
Guptal et al. 
[31]
86 Transperitoneal 121 2.3 9.3 2.5 13.6
Minnillo 
et al. [28]
155 Transperitoneal 198.5 0 11 1.95 31.7
Etafy et al. 
[32]
61 Transperitoneal 335 0 11.4 2 18
Sivaraman 
et al. [25]
168 Transperitoneal 134.9 0 6.6 1.5 39
Buffi et al. 
[33]
145 Both 120 2.8 8.3 4.7 24
Table 1. 
Comparative studies (more than 50 patients)
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Cestari et al. reported that both the retro- and transperitoneal RPs were safe and 
these were the feasible procedures with a low morbidity rate with an overall success 
rate of 96% [5].
Overall, the outcomes of the procedure have been defined as excellent and 
reproducible [22, 25, 26], with durable results [24].
The success rate reported [27] is high (81–100%), with reintervention rates 
between 0 and 13.1%. Operative times are more variable, ranging from 105 to 
335 min. They concluded RP to be a safe procedure with a reproducible high rate of 
successful outcomes, low conversion rates (0–4.8%), complication rates (2–17.9%), 
and a limited EBL.
Outcomes of RP in the pediatric population have been largely described in the 
literature. Minnillo et al. published the largest series, assessing 155 pediatric patients 
undergoing RP; a success rate of 96% with a 3% of failure rate was reported [28].
A recent meta-analysis of comparative studies in the pediatric population 
showed no difference in success rate between robotic and conventional laparoscopic 
pyeloplasty [29] with an overall success rate of 99.3% and 96.9%, respectively, with 
no significant difference between the two approaches. Complication and reopera-
tion rates were comparable between the two approaches. The length of hospitaliza-
tion was significantly shorter for the robotic group (Table 1).
A recent multi-institutional study [34] reported 407 pediatric cases treated with 
robotic pyeloplasty and found a complication rate of 13.8%. No high-grade compli-
cations were reported (Clavien Dindo IV or V).
3.1 Comparative studies
Autorino et al. published a meta-analysis that demonstrates no statistically 
significant difference in terms of success and complication rates between minimally 
invasive and open approach in the adult population; however, the minimally inva-
sive approaches provides a shorter hospital stay compared to open surgery [27].
Basatac et al. [35] confirmed the significant decrease in the length of hospital 
stay, estimated blood loss, earlier drainage removal, and the decrease of the need 
for painkillers. In terms of success rates, intraoperative complications, and conver-
sions, no significant differences were found.
Basatac et al. described a shorter time for robotic surgery although considering 
exclusively the console time. Hanske et al. [36], when evaluating a large number 
of patients undergoing minimally invasive versus open, reports a statistically 
significant difference in the percentage of patients requiring prolonged operation 
time (<236 min): 29.6% for minimally invasive pyeloplasty versus 15.3% for open 
pyeloplasty.
4.  Role of robotic approach in the management of recurrent 
ureteropelvic junction obstruction
The robotic approach is feasible, safe, and effective for treating recurrent 
obstruction [33]. Secondary minimally invasive pyeloplasty is obviously a more 
challenging procedure due to the fibrosis and the adhesions formed after the previ-
ous surgery. The precise movements with the robotic assistance and the amplified 
vision provide higher precision, thus, a bloodless dissection and a higher quality of 
the suture above all in complex patients.
RP in the treatment of secondary obstructions in pediatric series is reported 
with data from small series of patients. No comparative prospective studies were 
ever reported.
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Thom et al. found that nine secondary robotic procedures done at their center 
required longer operative time with an increased blood loss and failure rate (22%) 
[37]. Atug et al. show data from 7 patients undergoing redo RP. The outcomes were 
compared with data from a series of 37 patients that underwent RP for primary 
ureteropelvic junction obstruction. Mean operative time was 60 min longer in the 
secondary RP group. However, EBL, hospital stay, and overall success were compa-
rable [38].
Hemal et al. described the outcomes of 9 patients (mean age: 16.4 year) treated 
for secondary UPJO after failure of a previous open pyeloplasty and additionally 
failed endoscopic pyelotomy. All patients were treated robotically and reported 
clinical resolution of symptoms and no sign of residual obstruction at postoperative 
renal scan [39].
Data from a series of 20 patients treated for secondary obstruction were pub-
lished. Redo RP resulted successful in 94% of cases and the procedure was reported 
as feasible and safe [40].
Another series of 16 pediatric patients affected by secondary ureteropelvic 
junction obstruction is reported by Lindgren et al. [41]. These patients underwent 
redo RP following prior intervention, in specific, 12 underwent previous open 
surgeries and 4 RP. Redo RP and redo robotic ureterocalicostomy were performed 
in 13 and 3 patients, respectively. Overall resolution of symptoms was 100%, 
and radiographic test resolution or improvement was reported in 88% of cases. 
None of the patients needed further surgical treatment at an intermediate-term 
follow-up.
5. Single-site robot-assisted pyeloplasty
The treatment of UPJO is frequently performed in young patients. Thus, besides 
the resolution of the obstruction, the cosmetic result represents a crucial point in 
this population. Laparoendoscopic single site (LESS) pyeloplasty has been thought 
to reach this kind of goal [41, 42].
LESS is a complex approach, particularly due to suturing, even for urologists 
with an extended experience. This is due to the loss of instrument triangula-
tion and instrument clashing and to the reduced visibility and maneuverability 
associated with the coaxial orientation of instruments and of the laparoscope. 
The robotic technology minimizes the limitations associated with laparoendo-
scopic single site.
Robotic laparoendoscopic single site (R-LESS) pyeloplasty technique is per-
formed with the use of a 2.5 cm umbilical incision. Through this the single site port 
is inserted and the robot arms are connected (Figure 6) [43]. The GelPort system, 
introduced by a 3–5 cm umbilical incision, has also been employed to perform 
robotic LESS pyeloplasty [44] (Figure 7).
Data from a multicenter series of 30 cases reported the feasibility and safety of 
R-LESS pyeloplasty in highly selected patients. Only 2 patients were converted into 
a classic laparoscopic or robot-assisted approach. In three cases, an additional 3 mm 
trocar was needed. Success rate, at 13 months follow up, was comparable to rates 
reported in conventional robotic studies.
Exclusion criteria for this approach are a body mass index (BMI) >30 kg/m2, 
previous surgical procedure, an extremely dilated kidney pelvis (i.e., pelvis diam-
eter > 6 cm), complicated ureteropelvic junction obstruction with calculi, pelvic 
kidney, and horseshoe kidney [45, 46].
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R-LESS pyeloplasty is considered as a feasible and reproducible procedure in 
selected cases offering shorter hospitalization. Real advantages compared to the stan-
dard robot-assisted pyeloplasty are still to be shown in terms of operative outcome.
6. Buccal mucosal graft in pyeloplasty
Management of recurrent UPJO has lower success rate compared to primary 
treatment. Redo pyeloplasty can be challenging due to scar tissue and fibrosis that 
lead to larger resections to fin healthy and well-vascularized tissue for reanastomo-
sis. Buccal mucosal grafts (BMG), already in use for ureteral reconstruction, have 
been proposed in UPJO refractory to surgery and endoscopic treatment [47].
Figure 7. 
The GelPort system.
Figure 6. 
Da Vinci single site.
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The procedure consists in identifying the UPJO and dissecting longitudinally the 
anterior aspect of the stenosis. The incision is carried 1 cm proximally and distally 
to the stricture to ensure exposure of healthy tissue. 8-Fr double-J ureteral stents is 
placed robotically without the use of fluoroscopy. Single buccal graft is then har-
vested from the right inner cheek avoiding to compromise the Stensen ducts. The 
graft is placed as an anterior anastomotic onlay, over the ureteral and UPJ defect, 
with two 4-0 Vicryl sutures in a running fashion. The repair and entire surgical 
fields are wrapped in omentum after confirming the anastomoses are watertight 
with retrograde filling of the urinary collecting systems with methylene blue.
Although a handful of cases have been reported, it is a feasible and safe tech-
nique in both a pediatric and adult population. In the two studies, 3 and 2 patients 
were reported and a complete resolution of symptoms with a stable or improved 
ultrasound was seen at a median follow-up of 10 and 7 months, respectively. No 
postoperative complications were reported [48, 49].
7. The role of indocyanine green in redo pyeloplasty
The use of intraureteral injection indocyanine green (ICG) dye and subsequent 
visualization under near infra-red fluorescence (NIRF) has been used to facilitate 
robotic ureteral identification and reconstruction by aiding in rapid and accurate 
identification of the stricture margins. This can be particularly useful in case of 
recurrent UPJ interventions since the presence of fibrotic tissue may be a challenge 
to the surgeon [50, 51].
The procedure consists in inserting a 6-Fr ureteral catheter into the diseased 
ureter and 10 ml of ICG is injected retrogradely into the lumen, above and below 
the level of stenosis, and NIRF is used to guide our dissection; healthy tissue 
appears bright green and fibrotic, less perfused tissue, since it loses its transpar-
ency, appears darker giving precise localization of the proximal and distal stricture 
margins (Figure 8). Step-by-step procedure is shown in Figures 9–15.
Several series were published proving that the intraureteral injection of ICG is 
reproducible, safe, easy to perform, and involves minimal additional costs. All cases 
were clinically and radiographically successful, and no patient has required a repeat 
operation for stricture recurrence [50].
Figure 8. 
Intraureteral injection of indocyanine green in a redo pyeloplasty.
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Figure 9. 
Peritoneal incision.
Figure 10. 
Structures isolation.
Figure 11. 
Exposure of structures.
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Figure 13. 
Decrossing of the renal pelvis.
Figure 14. 
Anterograde ureteral stenting.
Figure 12. 
Ureteral Incision.
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8. Tips and tricks to approach robot-assisted pyeloplasty
Here, the steps where we think it is most important not to underestimate are 
described.
First of all particular attention should be given to the ports placement; although, it 
could sound trivial if you have a wrong port positioning the surgery might result chal-
lenging and the failure rate and risk of complications increase. During the diagnostic 
workout, a CT scan is performed not only to check for the presence of renal stones 
and a crossing vessel but also to understand the anatomy and the relationship of the 
kidney with the renal pelvis. The kidney can be ectopic, also called pelvic, and this 
would change the trocars placement. UPJO incidence reaches up to 22–37% of ectopic 
kidneys [52]. The camera port is still placed at the umbilicus level. The two operative 
robotic ports are positioned on the homolateral side as affected kidney 8 cm apart 
laterally on the same line as the camera and the 5-mm assistant port is positioned at 
the distal third on the line between the superior anterior iliac crest and the umbilicus.
Ureteral isolation is also fundamental for reducing the peri-operative risks and to 
better manage the ureter during the reconstruction phase. Several are the challenging 
scenarios where the importance of the ureteral isolation cannot be overstated. In the 
redo pyeloplasty, the fibrotic tissue makes both the identification and the handling of the 
structures more difficult and the risk of failure might increases if the ureter is not well 
isolated; as said the use of intraureteral ICG can help during this phase. Other scenarios 
can be encountered in the case of extra-rotated kidneys and intrarenal pelvis where the 
structures can be hidden and, in these cases, a partial isolation of the kidney and marker 
stitches can be placed to better expose the structures and a larger surgical field.
It is important not to underestimate the presence of calculi in the renal pelvis. In 
these cases, a flexible cystoscope can be inserted though one of the robotic trocars 
and consequently inserted into the real pelvis through a small incision previously 
performed. This is important as it allows stone extraction or even lithotripsy avoid-
ing spilling of water into the peritoneal cavity.
Finally, the ureteropelvic anastomosis if one of the most crucial phases of 
this kind of surgery as it is fundamental to have a continent anastomosis to avoid 
urinary fistulas, but is as important not to have an over tight suturing that would 
create again a stricture of the junction. Barbed sutures are advised as the barbs on 
its surface penetrate inside the tissue and lock them into place enabling the surgeon 
to adjust the tightness of the anastomosis.
Figure 15. 
Anastomosis.
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